Article
A Three-Gene Signature for Outcome in Soft Tissue Sarcoma
12 Aug 2009
Abstract excerpt
PURPOSE: Finding markers or gene sets that would further classify patients into different risk categories and thus allow more individually adapted multimodality treatment regimens in soft tissue sarcomas is necessary. In this study, we investigated the prognostic values of hypoxia-inducible factor 1a (HIF1a), heparin-binding epidermal growth factor-like growth factor (HB-EGF), vascular endothelial growth factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
